Market Reports Center One Stop Market Research Shop Generic Drugs Market Share, Size, Price, Growth, Trends and Forecast 2016 – 2020 Technavio Announces the Publication of its Research Report – Global Generic Drugs Market 2016-2020 Technavio recognizes the following companies as the key players in the global generic drugs market: Teva Pharmaceuticals, Sandoz, Allergan, Mylan, Sun Pharmaceuticals, and STADA Arzneimittel. Other Prominent Vendors in the market are: Abbott, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, Berlin Chemie, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Cipla, Coherus Biosciences, Dr. Reddy's Laboratory, Daiichi Sankyo, Eli Lilly, Emcure Pharmaceuticals, Eurofarma Laboratories, Gedeon Richter, Gilead Sciences, GlaxoSmithKline, Hospira, Impax, InnoPharma, Intas Pharmaceuticals, Jannsen, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus Pharmaceuticals, Novo Nordisk, Orchid Chemicals & Pharmaceuticals, Parenteral Drugs India, Par Pharmaceutical, Pfizer, Piramal (Abbott Laboratories), Roche Holdings, Sanofi, Synthon, Towa, Valeant Pharmaceuticals, Zentiva, Zhejiang Chiral, Medicine Chemicals, Zhejiang Hisun Pharmaceutical, and Zydus Cadila Healthcare. Download Brochure now @ https://marketreportscenter.com/reports/300740/global-generic-drugsmarket-2016-2020 Commenting on the report, an analyst from Technavio’ s team said: “One trend which is influencing market growth is the outsourcing of drug development. Vendors are increasingly using outsourcing as a business strategy as they have been experiencing a decline in venture capital investment. Some vendors outsource parts of their R&D process, such as product characterization testing, and toxicology testing, to contract research organizations. Similarly, some of them outsource parts or even the entirety of their manufacturing processes to other organizations. In this way, outsourcing is becoming a trend in the global generic drugs market.” According to the report, a key growth driver is the patent expiry of top selling drugs. With many pharmaceutical drugs set to lose their patents during the forecast period, the competition in the generic market is expected to increase. Patent expiry of a branded drug results in the introduction of inexpensive generic drugs in the market. Branded drugs with sales of up to $135 billion expired by the end of 2015, offering pharmaceutical companies opportunities to capitalize on this market. Moreover, the patent expiry of drugs worth $150 billion by 2020 will fuel the growth of the global generic drugs market. Further, the report states that one challenge that can have restrict market growth is the threat of counterfeit drugs. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors in the report global cardiovascular and metabolic disorders generic drugs market About the Generic Drugs Market Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics. Technavio’ s analysts forecast the global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global generic drugs market for 2016-2020. To calculate the market size, it considers revenue generated from the sales of simple generics, super generics, and biosimilars. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Teva Pharmaceuticals • Sandoz • Allergan • Mylan • Sun Pharmaceuticals • STADA Arzneimittel Other prominent vendors • Abbott • Amgen • Apotex • Aspen • AstraZeneca • Aurobindo Pharma • Baxter • Berlin-Chemie • Biocon • Biogen • Boehringer Ingelheim • Celltrion • Cipla • Coherus Biosciences • Dr. Reddy's Laboratory • Daiichi Sankyo • Eli Lilly • Emcure Pharmaceuticals • Eurofarma Laboratories • Gedeon Richter • Gilead Sciences • GlaxoSmithKline • Hospira • Impax • InnoPharma • Intas Pharmaceuticals • Jannsen • Lupin • Merck • Mitsubishi Tanabe Pharma • Momenta Pharmaceuticals • Natco Pharma • Nexus Pharmaceuticals • Novo Nordisk • Orchid Chemicals & Pharmaceuticals • Parenteral Drugs India • Par Pharmaceutical • Pfizer • Piramal (Abbott Laboratories) • Roche Holdings • Sanofi • Synthon • Towa • Valeant Pharmaceuticals • Zentiva • Zhejiang Chira Medicine Chemicals • Zhejiang Hisun Pharmaceutical • Zydus Cadila Healthcare Request for discount @ https://marketreportscenter.com/request-discount/300740 Market driver • Patent expiry of top-selling drugs • For a full, detailed list, view our report Market challenge • Threat of counterfeit drugs • For a full, detailed list, view our report Market trend • Outsourcing of drug development activities • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’ s time when you purchase this market report. Details are provided within the report. To Get Request Sample for this Reports: https://marketreportscenter.com/request-sample/300740 For more information content with us; Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com

Technavio recognizes the following companies as the key players in the global generic drugs market: Teva Pharmaceuticals, Sandoz, Allergan, Mylan, Sun Pharmaceuticals, and STADA Arzneimittel.